Search

everythinglearnresearchcommunity

for

Search:↓

Different wool coat types in goats are linked to specific gene expressions, which could improve cashmere quality.

Non-coding RNAs may be key in diagnosing and treating rare skin disorders.

DNA methylation of miR-365-1 causes hair follicle stem cell death by affecting DAP3.

TLR-targeted therapies show promise in cancer treatment by helping destroy tumors.

Nanotechnology can improve cervical cancer treatment by targeting drugs better and reducing side effects.

CRISPR/Cas systems show promise for cancer treatment by targeting miRNAs, but delivery and specificity challenges remain.

RNA delivery is best for in-body use, while RNP delivery is good for outside-body use. Both methods are expected to greatly impact future treatments.

Cell membrane-coated nanoparticles could improve gene therapy by enhancing delivery and targeting of nucleic acids.

New technologies show promise in healing wounds, treating cancer, autoimmune diseases, and genetic disorders.

Nanotechnology improves CRISPR-Cas9 delivery for cancer treatment, but challenges remain.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

New delivery systems are improving siRNA treatments for skin conditions.

Immunotherapies for non-small cell lung cancer show promise in improving treatment and reducing side effects.

New cancer treatments aim to reduce side effects and improve effectiveness.

Targeted radionuclide therapy shows promise for improving head and neck cancer treatment but needs more research.

Non-coding RNA boosts retinoic acid production and signaling, aiding regeneration.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

Developing microRNA-based treatments is hard but has potential.

Advancements in nanoformulations for CRISPR-Cas9 genome editing can respond to specific triggers for controlled gene editing, showing promise in treating incurable diseases, but challenges like precision and system design complexity still need to be addressed.

Self-amplifying RNA could be a better option for protein replacement therapy with lower doses and lasting effects, but delivering it into cells is still challenging.

New therapies for alopecia areata show potential but need more research.

Smart delivery methods for CRISPR gene editing are crucial for clinical success.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Non-viral delivery systems and stimuli-responsive nanoformulations can improve CRISPR-Cas9 gene therapy.

A specific RNA, circNlgn, contributes to heart damage and scarring caused by the cancer drug doxorubicin.

A new treatment using nanoliposomes can improve hair regrowth in androgenetic alopecia.

New CRISPR/Cas9 variants and nanotechnology-based delivery methods are improving cancer treatment, but choosing the best variant and overcoming certain limitations remain challenges.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Noncoding dsRNA boosts hair growth by activating TLR3 and increasing retinoic acid.